Laboratory of Cell Death Control BioTechnology, Hiroshima Prefectural University School of BioSciences, Shobara, Hiroshima 727-0023, Japan.
Biomed Pharmacother. 2010 Oct;64(8):565-71. doi: 10.1016/j.biopha.2010.02.005. Epub 2010 Mar 11.
Out of normal human fibroblasts OUMS-36 and three clones (T1, T2 and T3) of telomere reverse transcriptase gene (hTERT)-transfectants, telomere length is in order: T3 >T2 >T1 >>OUMS-36 (young) >>OUMS-36 (old), and telomerase activity is in order: T2 >T3 >T1 >>OUMS-36 (young, old), suggesting that telomere length may be roughly governed by telomerase activity. Telomere-like oligonucleotides [5'- (TTAGGG) (1-3)-3'] (ON mono-/di-/trimer) and a mononucleotide (T:A:G=2:1:3, mol/mol) mixture (MN mix), as candidates for telomerase activators, maintained above 80% of cell viability at marginally higher doses of 2 μM for MN-mix or ON monomer, 1 μM for ON dimmer and 0.67 μM for ON trimer, respectively, in OUMS-36 and T2 cells, and administered for 4 weeks, resulting in no elongation of telomere length in both the cell lines. In contrast, telomerase activity was enhanced by administration with ON mono-/di-/trimer, but not MN mix, in a manner dependent on treatment periods, in T2 transfectants, whereas similar effects were not observed in OUMS-36 parents. The 4-week treatment with ON mono-/di-/trimers, but not MN mix, also suppressed cell-viability diminishment induced by the oxidative-stressor tert-butylhydroperoxide in T2 cells, but scarcely in OUMS-36 cells. Thus, the promoting effects of oligonucleotide [5'-(TTAGGG)(1-3)-3'] on both telomerase enhancement and oxidative-stress resistance can be exerted for telomerase-abundant T2 hTERT-transfectants, but not for telomerase-poor OUMS-36 parents.
从正常人类成纤维细胞 OUMS-36 和端粒逆转录酶基因 (hTERT) 转染的三个克隆 (T1、T2 和 T3) 中,端粒长度依次为:T3>T2>T1>>OUMS-36(年轻)>OUMS-36(年老),端粒酶活性依次为:T2>T3>T1>>OUMS-36(年轻,年老),提示端粒长度可能大致受端粒酶活性的控制。端粒类似寡核苷酸[5'-(TTAGGG)(1-3)-3'](ON 单-/二-/三聚体)和单核苷酸(T:A:G=2:1:3,摩尔/摩尔)(MN 混合物)作为端粒酶激活剂的候选物,在 OUMS-36 和 T2 细胞中,MN 混合物或 ON 单体的边际高剂量 2 μM、ON 二聚体的 1 μM 和 ON 三聚体的 0.67 μM 时,保持超过 80%的细胞活力,给药 4 周后,在两种细胞系中端粒长度均无延长。相反,ON 单-/二-/三聚体给药可增强 T2 转染子中的端粒酶活性,但 MN 混合物则不能,其方式依赖于处理期,而在 OUMS-36 亲本中则未观察到类似作用。ON 单-/二-/三聚体治疗 4 周,但 MN 混合物治疗 4 周,也抑制了 T2 细胞中氧化应激剂叔丁基过氧化物诱导的细胞活力降低,但在 OUMS-36 细胞中则很少。因此,寡核苷酸[5'-(TTAGGG)(1-3)-3']对端粒酶增强和氧化应激抗性的促进作用可在端粒酶丰富的 T2 hTERT 转染子中发挥作用,但在端粒酶缺乏的 OUMS-36 亲本中则不能。